S
Sverre E. Kjeldsen
Researcher at University of Oslo
Publications - 771
Citations - 95426
Sverre E. Kjeldsen is an academic researcher from University of Oslo. The author has contributed to research in topics: Blood pressure & Left ventricular hypertrophy. The author has an hindex of 94, co-authored 735 publications receiving 89059 citations. Previous affiliations of Sverre E. Kjeldsen include University of Michigan & Cornell University.
Papers
More filters
Journal ArticleDOI
New guidelines for the prevention of cardiovascular disease.
Journal ArticleDOI
Changes in subclinical organ damage vs. in Framingham risk score for assessing cardiovascular risk reduction during continued antihypertensive treatment: a LIFE substudy.
Michael H. Olsen,Kristian Wachtell,Hans Ibsen,Lars H Lindholm,Sverre E. Kjeldsen,Per Omvik,Markku S. Nieminen,Björn Dahlöf,Peter M. Okin,Richard B. Devereux +9 more
TL;DR: Cornell product1year and UACR1year improved in contrast to FRS1year risk prediction based on FRSbaseline, Sokolow-Lyonbaseline and UacRbaseline significantly in LIFE patients during antihypertensive treatment.
Journal Article
ESH Hypertension Excellence Centres : A new strategy to combat an old foe
Journal ArticleDOI
8b.01: meta-analysis of five prospective and randomized controlled trials of renal sympathetic denervation on office and ambulatory systolic blood pressure in treatment resistant hypertension.
Fadl Elmula F,Yu Jin,Anne Cecilie K Larstorp,Alexandre Persu,Sverre E. Kjeldsen,Jan A. Staessen +5 more
TL;DR: In patients with TRH, the overall BP lowering effect of RDN is not superior to control, and RDN should not be considered as a treatment modality of RHT in clinical practice.
Journal ArticleDOI
2d.01: exercise systolic blood pressure >/=190 mmhg at moderate workload predicts coronary heart disease in healthy, middle-aged men
Julian E. Mariampillai,Kristian Engeseth,Sverre E. Kjeldsen,Irene Grundvold,Knut Liestøl,Gunnar Erikssen,Jan Erikssen,Johan Bodegard,Per Torger Skretteberg +8 more
TL;DR: The findings indicate that a systolic blood pressure of 190 mmHg or more at moderate workload is associated with future risk of CHD among apparently healthy middle-aged men.